KR930007882A - 세포독성 비시클로[7.3.1]트리데 - 4 - 센 - 2,6디인 화합물 및 그의 제조방법 - Google Patents

세포독성 비시클로[7.3.1]트리데 - 4 - 센 - 2,6디인 화합물 및 그의 제조방법 Download PDF

Info

Publication number
KR930007882A
KR930007882A KR1019920019668A KR920019668A KR930007882A KR 930007882 A KR930007882 A KR 930007882A KR 1019920019668 A KR1019920019668 A KR 1019920019668A KR 920019668 A KR920019668 A KR 920019668A KR 930007882 A KR930007882 A KR 930007882A
Authority
KR
South Korea
Prior art keywords
compound
hydrogen
alkyl
hydroxy
double bond
Prior art date
Application number
KR1019920019668A
Other languages
English (en)
Inventor
에프. 캐도우 존
디. 위트먼 마크
Original Assignee
도미니크 엠. 메짜펠
브리스톨-마이어즈 스퀴브 컴페니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 도미니크 엠. 메짜펠, 브리스톨-마이어즈 스퀴브 컴페니 filed Critical 도미니크 엠. 메짜펠
Publication of KR930007882A publication Critical patent/KR930007882A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/34—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/06—Cobalt compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/48—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing ten carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 에스페라미신의 아글리콘의 일부인 8-히드록시-비시클로[7,3,1]-트리데-4-센-2,6-디인 고리계의 새롭고도 효과적인 제조방법과 상기 비시클릭 고리계를 갖는 신규한 세포독성제제에 관한 것이다.
본 발명은 또한 악성종양에 걸린 포유동물에게 본 발명의 화합물의 항종양 유효량을 투여하는 것으로 되는, 종양치료 방법도 제공한다.

Description

세포독성 비시클로[7.3.1]트리데-4-센-2,6-디인 화합물 및 그의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (32)

  1. 다음 일반식을 갖는 화합물 또는 약리적으로 허용되는 그의 염.
    상기식중,----는 이중결합, 단일결합 또는 에폭시; Rx또는 Ry중 하나는 수소이고 다른 하나는 수소 또는 히드록시; 또는 Rx와 Ry는 함께 옥소기를 형성하고; RW는 수고, -C(O)Rs, -C(O)NRtRu또는 -C(O)ORv, Rz및 Rz1은 각각 수고, 또는 Rz나 Rz1중 하나는 수소이고 다른 하나는 히드록시, -OC(O)Rs, -OC(O)NRtRu또는 -OC(O)ORv이며, Rs는 수소, C1-8알킬, C3-6시클로알킬, C6-10아릴, C7-14아르알킬 또는 퀴놀살릴; Rt및 Ru는 독립적으로 소수, C1-8알킬, 아미노-치환된 C1-8알킬, C3-6시클로알킬, C6-10아릴, C7-14아르알킬, 피리딜 또는 퀴녹살릴이며; Rv는 C1-8알킬, 할로-치환된 C1-8알킬, C3-6시클로알킬, C6-10아릴 또는 C7-14아르알킬이고; Rw, Rx, 및 Rz1이 각각 수소이고,----가 이중 결합이면 Rz는 히드록시 아님.
  2. 제1항에 있어서, 다음 일반식을 갖는 화합물 또는 그의 약리적으로 허용되는 염.
    상기식중,----는 이중결합, 단일결합 또는 에폭시; Rx또는 Ry중 하나는 수소이고 다른 하나는 수소 또는 히드록시; 또는 Rx와 Ry는 함께 옥소기를 형성하고; RW는 수고, -C(O)Rs, -C(O)NRtRu또는 -C(O)ORv, Rz는 수소, 히드록시, -OC(O)Rs, -OC(O)NRtRu또는 -OC(O)ORv이며, Rs는 수소, C1-8알킬, C3-6시클로알킬, C6-10아릴, C7-14아르알킬 또는 퀴놀살릴; Rt및 Ru는 독립적으로 소수, C1-8알킬, 아미노-치환된 C1-8알킬, C3-6시클로알킬, C1-10아릴, C7-14아르알킬, 피리딜 또는 퀴녹살릴이며; Rv는 C1-8알킬, 할로-치환된 C1-8알킬, C3-6시클로알킬, C1-10아릴 또는 C7-14아르알킬이고; Rw, Rx, 및 Ry이 각각 수소이고,----가 이중 결합이면 Rz는 히드록시 아님.
  3. 제2항에 있어서, Rw가 수소인 것이 특징인 화합물.
  4. 제3항에 있어서, Rz가 히드록시, -C(O)Rs, -C(O)NRtRu또는 -C(O)ORv이고, Rs,Rt,Ru및 Rv는 제1항에서 정의된 바와 같으며; Rz및 Ry가 수소이고----가 이중결합이며, RZ는 히드록시가 아닌 것이 특징인 화합물.
  5. 제4항에 있어서, Rz와 Ry는 각각 수소이고----이 이중결합이면, RZ는 히드록시가 아닌 것이 특징인 화합물.
  6. 제5항에 있어서,----이 이중결합 또는 에폭시인 것이 특징인 화합물.
  7. 제6항에 있어서,----이 이중결합인 것이 특징인 화합물.
  8. 제7항에 있어서, Rz이 -OC(O)Rs이고, Rs는 수소, C1-8알킬 또는 퀴녹살린인 것이 특징인 화합물.
  9. 제7항에 있어서, Rz이 -OC(O)NRtRu이고, Rt는 수소, Ru는 C1-8알킬, 아미노-치환된 C1-8알킬, 피리딜 또는 퀴녹살릴이며; 또는 Rt및 Ru는 각각 C1-8알킬인 것이 특징인 화합물.
  10. 제7항에 있어서, Rz이 -OC(O)ORv;Rv는 할로-치환된 C1-8알킬인 것이 특징인 화합물.
  11. 제8항에 있어서, Rs가 메틸인 것이 특징인 화합물.
  12. 제8항에 있어서, Rs가 퀴녹살릴인 것이 특징인 화합물.
  13. 제8항에 있어서, Rs가 수소인 것이 특징인 화합물.
  14. 제8항에 있어서, Rs가 n-헵타노일인 것이 특징인 화합물.
  15. 제9항에 있어서, Rt가 수소이고 Ru는 메틸인 것이 특징인 화합물.
  16. 제9항에 있어서, Rt가 수소이고 Ru는 퀴녹살릴인 것이 특징인 화합물.
  17. 제9항에 있어서, Rt와 Ru가 각각 에틸인 것이 특징인 화합물.
  18. 제9항에 있어서, Rt가수소이고 Ru는 5-아미노펜틸인 것이 특징인 화합물.
  19. 제9항에 있어서, Rt가 수소이고 Ru는 2-피리딜인 것이 특징인 화합물.
  20. 제10항에 있어서, Rv가 2,2,2-트리클로로에틸인 것이 특징인 화합물.
  21. 제6항에 있어서,----가 각각 에틸인 것이 특징인 화합물.
  22. 제21항에 있어서, Rz이 히드록시인 것이 특징인 화합물.
  23. 제3항에 있어서, Rz이 수소인 것이 특징인 화합물.
  24. 제23항에 있어서,----가 단일 결합인 것이 특징인 화합물.
  25. 제24항에 있어서, Rx와 Ry가 각각 수소인 것이 특징인 화합물.
  26. 제23항에 있어서,----가 이중 결합인 것이 특징인 화합물.
  27. 제26항에 있어서, Rx와 Ry가 각각 수소인 것이 특징인 화합물.
  28. 제26항에 있어서, Rx와 Ry중 하나가 히드록시인 것이 특징인 화합물.
  29. 제26항에 있어서, Rx와 Ry가 함께 옥소기를 나타내는 것이 특징인 화합물.
  30. 제3항에 있어서, Rz이 히드록시이고, Rx또는 Ry중 하나는 히드록시이며 다른 하나는 수소이고,----는 이중결합인 것이 특징인 화합물.
  31. 제1항의 화합물에 민감한 악성 종양에 걸린 동물에게 제1항의 화합물의 항종양 유효량을 투여하는 것으로 이루어지는 제1항의 화합물에 민감한 악성 종양에 걸린 동물의 치료방법.
  32. 제1항의 화합물의 항종양 유효량과 약리적으로 허용되는 담체로 이루어지는 항종양 제약 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920019668A 1991-10-25 1992-10-24 세포독성 비시클로[7.3.1]트리데 - 4 - 센 - 2,6디인 화합물 및 그의 제조방법 KR930007882A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/782,942 US5198560A (en) 1990-04-27 1991-10-25 Cytotoxic bicyclo[7.3.1]tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
US782,942 1991-10-25

Publications (1)

Publication Number Publication Date
KR930007882A true KR930007882A (ko) 1993-05-20

Family

ID=25127668

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920019668A KR930007882A (ko) 1991-10-25 1992-10-24 세포독성 비시클로[7.3.1]트리데 - 4 - 센 - 2,6디인 화합물 및 그의 제조방법

Country Status (14)

Country Link
US (1) US5198560A (ko)
EP (1) EP0538898A3 (ko)
JP (1) JPH07242585A (ko)
KR (1) KR930007882A (ko)
CN (1) CN1071912A (ko)
AU (1) AU658230B2 (ko)
CA (1) CA2081007A1 (ko)
FI (1) FI924777A (ko)
HU (1) HUT62251A (ko)
IL (1) IL103516A0 (ko)
MX (1) MX9206064A (ko)
NZ (1) NZ244871A (ko)
TW (1) TW218867B (ko)
ZA (1) ZA928158B (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100476467B1 (ko) * 2001-07-24 2005-03-18 주식회사 코오롱 알칼리 이용성 폴리에스테르의 제조방법
KR20230055507A (ko) 2021-10-19 2023-04-26 농업회사법인 파인 주식회사 난황유 용매 추출시 잔유용매 제거방법

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214345B1 (en) 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
DK0871490T3 (da) * 1995-12-22 2003-07-07 Bristol Myers Squibb Co Forgrenede hydrazonlinkere
US6908978B2 (en) * 2001-11-02 2005-06-21 Bausch & Lomb Incorporated High refractive index polymeric siloxysilane compositions
TWI349422B (en) 2007-03-21 2011-09-21 Delta Electronics Inc Control system and method for tuning the system thereof
CA2836338C (en) 2011-05-16 2022-05-03 Koninklijke Philips N.V. Tetrazine derivatives used in bio-orthogonal drug activation
FI2922574T3 (fi) 2012-11-22 2023-08-11 Tagworks Pharmaceuticals B V Kemiallisesti pilkkoutuva ryhmä
RU2019105549A (ru) 2012-12-21 2019-03-28 Биоэллаенс К. В. Гидрофильные саморазрушающиеся линкеры и их конъюгаты
AU2015276821A1 (en) 2014-06-20 2017-01-12 Abgenomics International Inc. Anti-folate receptor aplha (FRA) antibody-drug conjugates and methods of using thereof
CN105218362B (zh) * 2015-08-28 2017-03-22 吉林大学 一种共轭炔酮的还原酰化反应方法
RU2766000C2 (ru) 2016-01-08 2022-02-07 АльтруБио Инк. Четырехвалентные антитела к psgl-1 и их применения
EP3474901A1 (en) 2016-06-27 2019-05-01 Tagworks Pharmaceuticals B.V. Cleavable tetrazine used in bio-orthogonal drug activation
US20210308207A1 (en) 2018-05-04 2021-10-07 Tagworks Pharmaceuticals B.V. Compounds comprising a linker for increasing transcyclooctene stability
WO2019212356A1 (en) 2018-05-04 2019-11-07 Tagworks Pharmaceuticals B .V. Tetrazines for high click conjugation yield in vivo and high click release yield
IL289094A (en) 2019-06-17 2022-02-01 Tagworks Pharmaceuticals B V Tetrazines for increasing the speed and yield of the "click release" reaction
US20230121556A1 (en) 2019-06-17 2023-04-20 Tagworks Pharmaceuticals B.V. Compounds for fast and efficient click release
ES2963003T3 (es) 2020-10-27 2024-03-22 Elucida Oncology Inc Conjugados de nanopartículas y fármacos dirigidos a receptor de folato y usos de los mismos
CN113214283B (zh) * 2021-04-12 2022-09-30 华南理工大学 一种呋喃大环化合物制备方法及制备的呋喃大环化合物和应用
WO2023158305A1 (en) 2022-02-15 2023-08-24 Tagworks Pharmaceuticals B.V. Masked il12 protein
WO2024080872A1 (en) 2022-10-12 2024-04-18 Tagworks Pharmaceuticals B.V. Strained bicyclononenes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2040855A1 (en) * 1990-04-27 1991-10-28 John F. Kadow Cytotoxic bicyclo¬7.3.1| tridec-4-ene-2,6-diyne compounds and process for the preparation thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100476467B1 (ko) * 2001-07-24 2005-03-18 주식회사 코오롱 알칼리 이용성 폴리에스테르의 제조방법
KR20230055507A (ko) 2021-10-19 2023-04-26 농업회사법인 파인 주식회사 난황유 용매 추출시 잔유용매 제거방법

Also Published As

Publication number Publication date
HU9203322D0 (en) 1992-12-28
AU2710892A (en) 1993-04-29
IL103516A0 (en) 1993-03-15
HUT62251A (en) 1993-04-28
EP0538898A2 (en) 1993-04-28
FI924777A (fi) 1993-04-26
AU658230B2 (en) 1995-04-06
FI924777A0 (fi) 1992-10-21
CA2081007A1 (en) 1993-04-26
NZ244871A (en) 1995-05-26
ZA928158B (en) 1993-04-28
MX9206064A (es) 1993-04-01
TW218867B (ko) 1994-01-11
US5198560A (en) 1993-03-30
JPH07242585A (ja) 1995-09-19
EP0538898A3 (en) 1993-06-23
CN1071912A (zh) 1993-05-12

Similar Documents

Publication Publication Date Title
KR930007882A (ko) 세포독성 비시클로[7.3.1]트리데 - 4 - 센 - 2,6디인 화합물 및 그의 제조방법
CA2188043A1 (en) 7,11 disubstituted camptothecin derivatives, formulations containing such derivatives and their use
KR940701264A (ko) 안과질환에 대한 마크로라이드 화합물의 용도
EP1070710A3 (en) Dithiolan derivatives, their preparation and their therapeutic effect
FI941537A (fi) Uudet tehokkaat, terminaalisen erilaistumisen indusoivat aineet sekä menetelmät niiden käyttämiseksi
GB1305546A (ko)
KR930010039A (ko) 인돌로피롤로카르바졸 유도체
DE3878198D1 (de) 11-arylsteroid-derivate.
ES2087163T3 (es) Preparacion antitumoral que comprende intreleucina-2 e histamina, analogo al de las mismas o agonistas de receptor h2.
KR930700451A (ko) 항암제로서의 비스-나프탈이미드
RU96111012A (ru) Пролекарства производных паклитаксела
PT87322A (pt) Novel 11-aryloestrane and 11-arylpregnane derivates
KR880001693A (ko) 신규의 18- 페닐오 에스트란 유도체
EP0383256A3 (en) A novel substituted-acetamide compound and a process for the preparation thereof
FR2446829A1 (fr) Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
KR860003242A (ko) 5-플루오로우라실 유도체의 제조방법
KR890011868A (ko) 간질환 치료제 및 피페라진 유도체
KR890003793A (ko) 3'-데메톡시에피포도필로톡신 배당체의 유도체
KR940701407A (ko) 레닌 억제제로서의 하이드록시아지도 유도체 및 관련 화합물
KR850006429A (ko) 새로운 시아노이미다졸 누클레오시드 유도체 및 그 제조방법
GB1274029A (en) Benzodiazepine derivatives
FR2630111B1 (fr) Nouveaux derives trieniques de structure chromenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB1398687A (en) Substituted oxazolidinones and pharmaceutical uses thereof
OA09324A (fr) "Procédé de préparation de (pyridyl-3)-2 tétrahydrothiopyrannecarbothioamide-2-oxydes-1-(1R,2R), les (pyridyl-3)-2 tétrahydrothiopyrannecarbothioamide-2-oxydes-1-(1R,2R) ainsi obtenus et les compositions pharmaceutiques qui les contiennent".
US4822782A (en) Method for treating AIDS using streptovaricin C compounds

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid